Pathstone Holdings, LLC 10x Genomics, Inc. Transaction History
Pathstone Holdings, LLC
- $22.3 Billion
- Q3 2024
A detailed history of Pathstone Holdings, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 23,214 shares of TXG stock, worth $340,549. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,214
Previous 22,471
3.31%
Holding current value
$340,549
Previous $437,000
19.91%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding TXG
# of Institutions
291Shares Held
94.7MCall Options Held
263KPut Options Held
85.1K-
Vanguard Group Inc Valley Forge, PA11MShares$161 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.8MShares$158 Million2.31% of portfolio
-
Morgan Stanley New York, NY6.48MShares$95 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$93.8 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.37MShares$93.5 Million0.1% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.39B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...